Valuation Abbott Laboratories Lima

Stocks

End-of-day quote Lima 24/08/2026			5-day change	1st Jan Change
110.37 ^USD	0.00%		+1.61%	-16.13%

26/08	Abbott Receives Fda Authorization for Libre Duo 10 Day Dual Glucose-Ketone Sensing Technology	CI
26/08	Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,41,365	1,91,427	1,91,088	1,96,184	2,17,859	2,01,884	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-7.33%	-	-
Enterprise Value (EV) ¹	2,49,166	1,98,318	1,98,871	2,02,693	2,22,266	2,25,823	2,22,841	2,19,151
Change	-	-20.41%	0.28%	1.92%	9.66%	1.6%	-1.32%	-1.66%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	33.5x	25.8x	23x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	4.22x	4.04x	3.83x
PEG	-	-36.9x	-2x	0x	-0.7x	-5.33x	0.9x	1.9x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	4.01x	3.69x	3.46x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	4.49x	4.08x	3.75x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	17.3x	15.3x	13.7x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	19.3x	17.1x	15.3x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	28.5x	23.8x	21.5x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.51%	4.2%	4.66%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.571	2.741	2.896
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.2%	2.35%	2.48%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.486	4.524	5.074
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	73.7%	60.6%	57.1%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,302	54,646	58,409
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	13,090	14,598	16,020
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,719	13,021	14,313
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,232	7,924	8,850
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	116.67	116.67	116.67
Nbr of stocks (in thousands)	17,14,968	17,43,574	17,36,059	17,34,455	17,38,834	17,30,383	-	-
Announcement Date	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT LABORATORIES	33.47x	4.49x	17.25x	2.2%	20TCr
MEDTRONIC PLC	20.92x	3.61x	12.74x	3.2%	12TCr
CENCORA, INC.	17.73x	0.21x	12.94x	0.74%	6.18TCr
HOYA CORPORATION	30.33x	7.54x	19.27x	1.32%	5.23TCr
BECTON, DICKINSON AND COMPANY	36.76x	3.52x	12.05x	2.06%	5.2TCr
DEXCOM, INC.	36.5x	6.42x	20.17x	-.--%	3.44TCr
MEDLINE INC.	45.55x	1.29x	11.82x	0.17%	3.04TCr
WEST PHARMACEUTICAL SERVICES, INC.	41.2x	7.22x	25.91x	0.26%	2.49TCr
TERUMO CORPORATION	20.05x	3.09x	11.28x	1.43%	2.41TCr
Average	31.39x	4.15x	15.94x	1.26%	6.67TCr
Weighted average by Cap.	29.94x	4.06x	15.65x	1.82%